Code | 7056E | ||||||||||
MA number | EU/1/24/1819/001 | ||||||||||
Product Form: | sol inj 1x2 ml/0,88 mg (liek.inj.skl.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Baxter Holding B.V., Netherland | ||||||||||
Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 27.06.2024 |
Validity: | 27.06.2029 |
SmPC + PL: |
|
Safety feature | Yes |
Data update: | 12.08.2024 |